OAKVILLE, Ontario, Aug. 14, 2018 /PRNewswire/ -- Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empoweringthe medical cannabis and mental health communities with next-generation digital solutions, today gave an update on the development of its veterinary informatics solution for Companion Healthcare Technologies, Inc. (CHT), a company engaged in partnering,
CHT and Ehave have identified the emerging market opportunity for the use of medical cannabis in the care of companion animals, and the development of the informatics platform enhancements will incorporate the tracking of safety and efficacy data for animals who are prescribed cannabis. In addition, Ehave Connect platform's capabilities in managing clinical trials will enable CHT's customers to efficiently capture, track and manage high quality comprehensive data that can prove that cannabis works for pets.
"We have seen the recent market activity supporting the study and creation of safe and effective cannabis products for pets," said Prateek Dwivedi, CEO of Ehave. "The Ehave platform for veterinary informatics that CHT has licensed will now embrace our core cannabis expertise. For day-to-day companion healthcare, trials of new cannabis therapies for pets, and the study of companion animals in pre-clinical trials for human cannabis therapeutics the Ehave platform will ensure that reliable data exists a for clinicians to understand what to prescribe, pet owners to feel confident in treatments, and drug developers to design new therapies."
Under the license agreement, CHT has exclusive rights to Ehave's informatics platform for use, in any indication, in companion animals. Development has begun to integrate Ehave's platform across the entire companion animal clinical pathway and related developments in the acceleration of quality of healthcare; allowing for consistent, consolidated data acquisition and analysis.
About EhaveEhave, Inc. (OTCQB: EHVVF) is empowering the medical cannabis and mental healthcare community with a next generation of data-rich tools designed to improve patient management, diagnosis and treatment. With Ehave Connect, Ehave's mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems ("MHS"), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder ("ADHD"), through its collaboration with the Hospital for Sick Children ("SickKids"). Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with leading medical cannabis licensed producers. www.ehave.com
About CHTCompanion Healthcare Technologies, Inc. ("CHT") is a private company engaged in partnering, licensing and incubating healthcare technologies with direct value to veterinary patients to improve the quality of care of companion animals and to improve treatment outcomes. CHT, along with its partner organizations, work closely with human healthcare companies and institutions to access cutting edge diagnostic and therapeutic products for translation to companion animal care. Companion Healthcare Technologies, Inc. ("CHT") is a private company engaged in partnering, licensing and incubating healthcare technologies with direct value to veterinary patients to improve the quality of care of companion animals and to improve treatment outcomes. CHT, along with its partner organizations, work closely with human healthcare companies and institutions to access cutting edge diagnostic and therapeutic products for translation to companion animal care.
Investor Relations Contact
David Kugelmandk@atlcp.com(866) 692-6847
View original content:http://www.prnewswire.com/news-releases/ehave-provides-update-on-companion-animal-informatics-platform-to-include-use-of-medical-cannabis-300696542.html
SOURCE Ehave, Inc.
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All